Cargando…
Lateral Flow Immunoassays for SARS-CoV-2
The continued circulation of SARS-CoV-2 virus in different parts of the world opens up the possibility for more virulent variants to evolve even as the coronavirus disease 2019 transitions from pandemic to endemic. Highly transmissible and virulent variants may seed new disruptive epidemic waves tha...
Autores principales: | Ang, Geik Yong, Chan, Kok Gan, Yean, Chan Yean, Yu, Choo Yee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689684/ https://www.ncbi.nlm.nih.gov/pubmed/36428918 http://dx.doi.org/10.3390/diagnostics12112854 |
Ejemplares similares
-
Nucleic Acid-Based Diagnostic Tests for the Detection SARS-CoV-2: An Update
por: Yu, Choo Yee, et al.
Publicado: (2021) -
Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
por: Chan, Kok Gan, et al.
Publicado: (2021) -
Genomic Surveillance of SARS-CoV-2 in Malaysia during the Era of Endemic COVID-19
por: Lee, Tze Yan, et al.
Publicado: (2023) -
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
por: Owen, Sophie I., et al.
Publicado: (2022) -
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
por: Spicuzza, Lucia, et al.
Publicado: (2023)